Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565) |
---|
08/03/1993 | US5232917 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
08/03/1993 | CA1320946C 11 .beta.-phenyl-4,9,15-estratrienes their manufacture and pharmaceut ical preparations containing same |
07/22/1993 | WO1993014107A1 Process for preparing 3-acylestratrienes and acylbenzenes |
07/22/1993 | CA2127274A1 Process for preparing 3-acylestratrienes and acylbenzenes |
07/13/1993 | US5227375 Androstanediones, estrogen-dependent diseases, anticancer |
07/06/1993 | US5225569 Process for precursors to calcitriol and related compounds |
06/30/1993 | EP0549318A2 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same |
06/30/1993 | EP0548884A1 Biphosphonate derivative |
06/30/1993 | EP0548824A1 Novel tricyclic steroid analogs |
06/30/1993 | EP0548793A2 Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor |
06/29/1993 | CA1319681C Platinum derivatives and cancer treatments |
06/27/1993 | CA2086026A1 Bisphosphonate derivative |
06/24/1993 | WO1993012083A1 22-oxacholecalciferol derivative and production thereof |
06/24/1993 | WO1993011772A1 Glycosylated steroid derivatives for transport across biological membranes and process for making same |
06/24/1993 | DE4143142A1 New 3-methyl sulphonyl hydrazono-steroid derivs. have antiandrogen activity - used to treat benign prostate hyperplasia and androgen dependent prostate carcinoma |
06/24/1993 | CA2117332A1 Glycosylated steroid acid derivatives for transport across biological membranes and process for making same |
06/21/1993 | CA2085830A1 Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors |
06/21/1993 | CA2085819A1 Novel tricyclic steroid analogs |
06/10/1993 | WO1993010741A2 Sex steroid activity inhibitors |
06/09/1993 | EP0545409A1 Liquid crystals with end groups containing more than one silane group |
06/09/1993 | EP0321572B1 Pregnane derivatives and process for their preparation |
06/08/1993 | US5218109 Steroid compounds |
06/07/1993 | CA2084562A1 Liquid crystals with (polysila) alkyl wing groups |
06/01/1993 | US5216015 Compounds having hypocholesterolemic properties |
06/01/1993 | US5215972 Internal nitrogen salts; antichloresterol agents |
05/27/1993 | WO1993010141A2 Angiostatic steroids |
05/27/1993 | CA2425846A1 Angiostatic steroids |
05/25/1993 | CA1318315C Ester of ascorbic acid 2-phosphate |
05/18/1993 | CA1317932C 9.,11.beta.-substituted and 11.beta.-substituted estranes |
05/05/1993 | EP0539466A1 Pt-CONTAINING COMPOUND, PROCESS FOR ITS PREPARATION, AND APPLICATION OF SUCH COMPOUNDS. |
05/04/1993 | CA1317283C Steroidal 17-silyl ethers and process to corticoids and progesterones |
04/29/1993 | WO1993007883A1 Derivatized oligonucleotides having improved uptake and other properties |
04/27/1993 | US5206415 Modulation of gamma-aminobutyric acid receptor channel function |
04/21/1993 | EP0423293B1 Decorative composition |
04/20/1993 | US5204337 Estrogen nucleus derivatives for use in inhibition of sex steroid activity |
04/07/1993 | EP0535595A2 Manufacture and use of novel glycosides of catechol estrogens |
03/31/1993 | EP0533703A1 Steroids which inhibit angiogenesis |
03/23/1993 | US5196542 Phospholipase A2 inhibitors |
03/23/1993 | US5196411 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors |
03/23/1993 | CA1314871C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents |
03/23/1993 | CA1314870C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents |
03/18/1993 | WO1993005063A1 Steroid sulphatase inhibitors |
03/04/1993 | WO1993003732A1 Gaba receptor modulators |
02/24/1993 | EP0528485A1 17Beta-acyl-3-androsta-3,5-dienes as testosterone 5alpha-reductase inhibitors |
02/24/1993 | EP0528209A1 Process for preparing intermediates for vitamin D derivatives and novel compounds obtained thereby |
02/23/1993 | CA1313864C Phospholipid conjugates and their preparation |
02/17/1993 | CA2067265A1 17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5.alpha.-reductase inhibitors |
02/16/1993 | US5187299 Cyclic hydrocarbons with an aminoalkyl sidechain |
02/16/1993 | CA1313653C 7-substituted 19-nor steroids; process for preparing them; their use as drugs and pharmaceutical compositions containing them |
02/02/1993 | US5183815 Bone acting agents |
01/26/1993 | US5182396 1-hydroxyvitamin d derivatives |
01/26/1993 | US5182393 Process for precursors to calcitriol and related compounds |
01/26/1993 | US5182381 Intermediates for 3-keto-19-nor-Δ4,9 -steroids |
01/05/1993 | US5177064 Targeted drug delivery via phosphonate derivatives |
12/29/1992 | US5175320 Anticholesterol agents |
12/29/1992 | US5175154 Antiobesity, antidiabetic, antilipemic, anticholesterol agents |
12/24/1992 | DE4120124A1 Cholesterol derivs. prodn. in one-pot process - by treatment of protected halo:alkanol with magnesium-anthracene and reaction with electrophilic steroid |
11/24/1992 | US5166139 Antiinflammatory agents |
11/24/1992 | CA1310631C 17.alpha.-HALOGEN-VINYLE-STRANES |
11/10/1992 | CA1310009C Ester prodrugs of steroids |
10/20/1992 | US5157031 Method for prophylaxis of obesity |
10/20/1992 | CA1309088C 17.beta.-(CYCLOPROPYLOXY)ANDROST-5-EN-3.beta.-OL AND RELATED COMPOUNDS USEFUL ASC -- -LYASE INHIBITORS |
10/14/1992 | EP0378563B1 Conversion of steroidal 17-cyanohydrins to corticoids |
09/30/1992 | WO1992017185A1 Targeted drug delivery via mixed phosphate derivatives |
09/30/1992 | EP0506388A1 1-Hydroxyvitamin D derivatives |
09/30/1992 | CA2108041A1 Targeted drug delivery via mixed phosphate derivatives |
09/29/1992 | CA1308095C 11.beta.-ARYLESTRADINENES, THE PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
09/17/1992 | WO1992015604A1 Anti-testosterone compounds and method of use thereof |
09/16/1992 | EP0503388A1 Pregna-21-oic acid esters |
09/15/1992 | US5147859 Complexes of glycerrhetinic acid with phospholipids and pharmaceutical and cosmetic compositions containing them |
09/08/1992 | US5145874 Cyclic hydrocarbons with an aminoalkyl sidechain |
09/05/1992 | CA2061906A1 Novel steroid derivative |
09/03/1992 | WO1992014746A1 Starting compounds for preparing calcitriol and its derivatives, method for preparing these starting compounds and intermediate products for this method |
09/03/1992 | WO1992014493A1 Non-protein intracellular receptor binding conjugates and a method of use thereof |
09/01/1992 | US5144017 Steroids |
08/20/1992 | DE4105503A1 Ausgangsverbindungen zur herstellung von calcitriol sowie dessen abkoemmlingen, verfahren zur herstellung dieser ausgangsverbindungen sowie zwischenprodukte fuer dieses verfahren Starting compounds for the production of calcitriol and its derivatives, process for manufacturing output, of such and intermediates for this process |
08/06/1992 | WO1992012989A1 New sterol esters and sterol phosphorus compounds |
08/06/1992 | WO1992012983A1 A method of fluorinating by using n-fluoropyridinium pyridine heptafluorodiborate |
07/29/1992 | EP0496520A1 Novel bone acting agents |
07/23/1992 | CA2059421A1 Bone acting agents |
07/21/1992 | US5132299 Antigestagenic, antiglucocorticoid |
06/30/1992 | US5126488 2β,19-methyleneamino bridged steroids as aromatase inhibitors |
06/30/1992 | US5126330 Sialosyl cholesterol and neuropathy remedy comprising the same |
06/17/1992 | EP0489779A1 Ophthalmic composition |
06/17/1992 | EP0356454B1 Cyclic hydrocarbons with an aminoalkyl sidechain |
06/11/1992 | WO1992009619A1 2β,19-METHYLENEAMINO BRIDGED STEROIDS AS AROMATASE INHIBITORS |
06/09/1992 | US5120847 Chemical intermediate which can be dehydrohalogenation |
06/02/1992 | US5118671 Complexes of aescin, β-sitosterol or cholesterol, and phospholipids and pharmaceutical compositions containing them |
06/02/1992 | CA1302401C Process for the preparation of 21-hydroxy-20-keto-delta__ -steroids and new intermediate compounds formed in this process |
05/26/1992 | US5116983 Dehydrogenation process intermediates |
05/26/1992 | US5116830 Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses |
05/20/1992 | EP0485392A1 Androgen derivatives for use in the inhibition of sex steroid activity |
05/20/1992 | EP0428707A4 Steroid modified oligonucleotides |
05/12/1992 | US5112998 Intermediates for vitamin D3 |
05/12/1992 | CA1300601C Estrane and androstane derivatives, process for producing them and preparations containing these compounds |
04/21/1992 | US5106963 For liposome immunology |
03/19/1992 | WO1992005187A1 NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM |
03/19/1992 | DE4029499A1 Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New 17- (beta) -oestradiolderivate, process for their production and pharmaceutical compositions containing them |
03/19/1992 | CA2091268A1 17-.beta.-oestradiol derivatives, processes for their preparation and medicaments containing these compounds |
03/18/1992 | EP0308412B1 16$g(a)-METHYLATION PROCESS |